Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nahome Fisseha"'
Autor:
Victor S.C. Fung, Jason Aldred, Martha P. Arroyo, Filip Bergquist, Agnita J.W. Boon, Manon Bouchard, Sarah Bray, Sara Dhanani, Maurizio F. Facheris, Nahome Fisseha, Eric Freire-Alvarez, Robert A. Hauser, Anna Jeong, Jia Jia, Pavnit Kukreja, Michael J. Soileau, Amy M. Spiegel, Saritha Talapala, Arjun Tarakad, Enrique Urrea-Mendoza, Jorge Zamudio, Rajesh Pahwa
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 10, Iss , Pp 100239- (2024)
Background: As Parkinson's disease (PD) advances, management is challenged by an increasingly variable and inconsistent response to oral dopaminergic therapy, requiring special considerations by the provider. Continuous 24 h/day subcutaneous infusion
Externí odkaz:
https://doaj.org/article/ee4b4d82effb4c59b7e2610de99a7111
Autor:
Hana Florian, Deli Wang, Steven E Arnold, Mercè Boada, Qi Guo, Ziyi Jin, Hui Zheng, Nahome Fisseha, Hari Varun Kalluri, Beatrice Rendenbach-Mueller, Kumar Budur, Michael Gold
Publikováno v:
Brain. 146:2275-2284
Tau accumulation in patients with Alzheimer’s disease tracks closely with cognitive decline and plays a role in the later stages of disease progression. This phase 2 study evaluated the safety and efficacy of tilavonemab, an anti-tau monoclonal ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::482fb4495fe23134b00634e5fe05dc2b
https://doi.org/10.1093/brain/awad024
https://doi.org/10.1093/brain/awad024
Autor:
Drew Kern, Khashayar Dashtipour, Jason Aldred, Thomas Kimber, Robert Iansek, Pavnit Kukreja, Lars Bergmann, Nahome Fisseha, Resmi Gupta, Saritha Talapala, Anna Jeong, Victor Fung, Vincent Lepetit
Publikováno v:
Tuesday, April 25.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e58de2f731cf06f75b99cbc3a83713e6
https://doi.org/10.1212/wnl.0000000000201730
https://doi.org/10.1212/wnl.0000000000201730
Autor:
Wassilios G. Meissner, Roberto Eleopra, Taku Hatano, Francisco Grandas, Joseph F. Quinn, Justyna Sarna, Hui Zheng, Osamu Onodera, John T. Slevin, Theresa A. Zesiewicz, Anwar Ahmed, Erika Driver-Dunckley, Tao Xie, Hidek Mochizuki, Deborah A. Hall, John O`Sullivan, Peter A. Ljubenkov, Carlo Colosimo, Tomoko Oeda, Luc Defebvre, Diana R. Kerwin, Hana Florian, Deli Wang, Hoi-Kei Lon, David S. Geldmacher, Nahome Fisseha, Jennifer Hui, Elizabeth Peckham, Noriko Nishikawa, Jean-Christophe Corvol, Günter U. Höglinger, Jared Brosch, Fabienne Ory-Magne, Alberto Albanese, Kumar Budur, Yvette Bordelon, Zbigniew K. Wszolek, Stefano Ruggieri, Akio Kikuchi, James H. Bower, Kelly Bertram, Antonio Daniele, Daryl Wile, Ikuko Aiba, Rajeev Kumar, Lawrence S. Honig, Daniel Claassen, Victor S.C. Fung, Renato P. Munhoz, Beatrice Rendenbach-Mueller, Michael Gold, Ziyi Jin, Albert C. Ludolph, Nuno Mendonca, Ronald B. Postuma, John C. Morgan, Alexandre Eusebio, Aldo Quattrone, Antoine Duquette, Pablo Mir Rivera, Irene Litvan, Thomas E. Kimber, Michele Tagliati, Paola Cudia, Stefan Lorenzl, Takashi Kimura, Zoltan Mari, Hideki Oizumi, Nikolaus R. McFarland, Davis C. Ryman, Lawrence I. Golbe, Paul E Schulz
Publikováno v:
The lancet / Neurology 20(3), 182-192 (2021). doi:10.1016/S1474-4422(20)30489-0
Summary Background Progressive supranuclear palsy is a neurodegenerative disorder associated with tau protein aggregation. Tilavonemab (ABBV-8E12) is a monoclonal antibody that binds to the N-terminus of human tau. We assessed the safety and efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a58b45d2df91f5a39e5802eb0fcc0d
https://doi.org/10.1016/s1474-4422(20)30489-0
https://doi.org/10.1016/s1474-4422(20)30489-0
Autor:
Michael J Soileau, Jason Aldred, Kumar Budur, Nahome Fisseha, Victor SC Fung, Anna Jeong, Thomas E Kimber, Kevin Klos, Irene Litvan, Daniel O'Neill, Weining Z Robieson, Meredith A Spindler, David G Standaert, Saritha Talapala, Eleni Okeanis Vaou, Hui Zheng, Maurizio F Facheris, Robert A Hauser
Publikováno v:
The Lancet. Neurology. 21(12)
Levodopa is the most effective symptomatic therapy for Parkinson's disease, but patients with advanced Parkinson's disease develop motor fluctuations with chronic oral levodopa therapy. Foslevodopa-foscarbidopa is a soluble formulation of levodopa an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5199f4d245882a1f2726f13dcb5c1896
https://pubmed.ncbi.nlm.nih.gov/36402152
https://pubmed.ncbi.nlm.nih.gov/36402152
Autor:
Kimberly Crimin, Patricia J Allen, Iman Abba, Corinne Ahlberg, Luke Benz, Hiuyan Lau, Jingshu Liu, Fareed Melhem, Nahome Fisseha, Hana Florian
Publikováno v:
Alzheimer's & Dementia. 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5906f0c9d0932856e3ac50fa7df48f0
https://doi.org/10.1002/alz.052361
https://doi.org/10.1002/alz.052361
Autor:
Dustin W. Wooten, Qi Guo, Ziyi Jin, Scott Gladstein, Edwin Stage, Jacob Hesterman, Nahome Fisseha, Hana Florian, Robert A. Comley
Publikováno v:
Alzheimer's & Dementia. 17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27284de1af7839c99d9ee02e8c3bbe53
https://doi.org/10.1002/alz.052183
https://doi.org/10.1002/alz.052183